MktsMarkets

Oscar Health, Inc.
NYSE: OSCRKey statistics
OSCR News
Stories mentioning OSCR from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 5,718 | 8,965 | 8,801 | 6,497 | 4,330 | 4,812 | 4,899 | 5,231 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 706,234 | 511,031 | 521,592 | 534,485 | 482,759 | 465,820 | 460,377 | 435,206 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 704,085 | (333,747) | (129,250) | (230,483) | 297,123 | (147,731) | (48,374) | 67,812 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | 698,773 | (352,681) | (139,291) | (233,536) | 288,211 | (153,689) | (52,312) | 60,949 |
| Tax Provision | 19,750 | (247.00) | (1,807) | (5,045) | 12,705 | (404.00) | 2,076 | 4,637 |
| Net Income (Loss) | 678,996 | (352,611) | (137,450) | (228,361) | 275,271 | (153,547) | (54,596) | 56,207 |
| Earnings Per Share (Basic) | 2.28 | (1.34) | (0.53) | (0.89) | 1.10 | (0.64) | (0.22) | 0.24 |
| Earnings Per Share (Diluted) | 2.07 | (1.34) | (0.53) | (0.89) | 0.92 | (0.58) | (0.22) | 0.20 |
| Weighted Average Shares Outstanding (Basic) | 298,184 | 262,388 | 259,273 | 255,531 | 251,279 | 240,386 | 243,106 | 238,672 |
| Weighted Average Shares Outstanding (Diluted) | 329,751 | 262,388 | 259,273 | 255,531 | 305,938 | 265,853 | 243,106 | 303,965 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About OSCR
Oscar Health, Inc. (NYSE: OSCR) is a stock listed on the New York Stock Exchange under the ticker symbol OSCR. It last traded at $25.89 (Nov 20, 2026, 11:12 AM ET), down 1.1% on the day. That gives Oscar Health a market capitalisation of $8.1B and a price-to-earnings ratio of 14.7.
Over the past 52 weeks OSCR has traded between $10.69 and $38.50.
Revenue for the quarter ended Mar 31, 2026 was $5.7M; net income $679.0M. Revenue was up 32.1% from $4.3M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $5.7M | $679.0M | 11874.7% |
| Dec 31, 2025 | $9.0M | -$352.6M | -3933.2% |
| Sep 30, 2025 | $8.8M | -$137.5M | -1561.8% |
| Jun 30, 2025 | $6.5M | -$228.4M | -3514.9% |
From Oscar Health’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…